Arbutus Biopharma Corp Annual Shareholders Meeting Transcript
Ladies and gentlemen, thank you for standing by and welcome to Arbutus Biopharma Annual General Meeting Conference Call.
(Operator Instructions)
I would now like to hand the conference over to your speaker today, Bill Collier. Thank you. Please go ahead, sir.
Thank you, and good morning, and welcome to Arbutus Biopharma Corporation's 2020 Annual General and Special Meeting of Shareholders. I'm Bill Collier, President and Chief Executive Officer of Arbutus, and I'll be presiding over the meeting today.
To all of our shareholders, I want to wish the best for you, your families and your communities in these uncertain unprecedented times. We're pleased to host today's meeting through this virtual meeting platform in order to ensure the health and welfare of our shareholders, directors and management in the light of the COVID-19 pandemic.
At this time, the meeting is called to order. I would first like to introduce Elizabeth Howard, Arbutus'
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |